# RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 1 - COMMERCIALIZATION CENTER

> **NIH NIH N02** · VENTUREWELL · 2024 · $478,706

## Abstract

The goal of the Commercialization Center for the RADx Blueprint MedTech Translator Cohort 1 is to provide technical, clinical, and commercialization expertise and resources while seeking to accelerate the development of devices to diagnose and treat disorders of the nervous system. The Commercialization Center is a trans-NIH focused activity that requires professional services support across a range of commercialization domains to NIH translational activities. To support rapid technology development, consultants with specialized domain expertise are needed to assess and mitigate risks at various stages.

## Key facts

- **NIH application ID:** 11220029
- **Project number:** 75N92022D00013-0-759202400003-1
- **Recipient organization:** VENTUREWELL
- **Principal Investigator:** MARK MARINO
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $478,706
- **Award type:** —
- **Project period:** 2024-07-17 → 2025-07-16

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11220029

## Citation

> US National Institutes of Health, RePORTER application 11220029, RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 1 - COMMERCIALIZATION CENTER (75N92022D00013-0-759202400003-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11220029. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*